Reproductive Surgery Sterilization and Reversal

Vasectomy Reversal Provides Symptomatic Relief in Patients With Postvasectomy Pain Syndrome: A Systematic Review

Lahiji R, Safdar B, Abdollahzadeh A, McKenzie J, Hong C, Braunschweig A, De Jesus-Escano M, Palmateer G, Patil D, Master VA, Cimmino CB

Published March 2026 Urology practice, 13(2), 166-171
DOI 10.1097/UPJ.0000000000000909 PMID 41104924

RRM Academy Synopsis

Case series report vasectomy reversal reduced postvasectomy pain

A review of five case series covering 123 men found that every series reported less pain after vasectomy reversal in men with postvasectomy pain syndrome. Four series were retrospective and one was prospective.

Key Findings

  • The review included 5 studies with 123 patients, covering vasovasostomy, vasoepididymostomy and robotic-assisted reversal. All 5 studies reported improved pain after reversal.
  • Lee and colleagues followed 22 men after vasovasostomy: 15 reported complete resolution of pain and 7 reported improvement. No man reported a relapse or lack of improvement.
  • Polackwich and colleagues reported 31 men whose mean pain score fell from 6.4 to 2.7 out of 10, a 60% change in reported pain.
  • Horovitz and colleagues reported that 13 of the 14 vasovasostomies improved pain, and 13 of the 14 men said they would undergo the same operation again.

Interpretation

The review brings together five case series published from 2010 to 2015. The authors said the studies were too small and too different to combine statistically. They call for larger prospective studies across several centers and for randomized trials against other treatments.

RRM Context

Restorative reproductive medicine looks for the structural source of a symptom and repairs it. Vasectomy reversal reconnects the tract that the vasectomy cut. The reviewed studies measured relief of chronic testicular pain in the male partner, part of couple-centered care.

Abstract

Introduction

Postvasectomy pain syndrome (PVPS) is a poorly understood, chronic condition affecting up to 5% of men post vasectomy. With limited evidence guiding its management, vasectomy reversal (VR) has been referenced as a potential treatment modality. This systematic review evaluates the current literature on the efficacy of VR in relieving PVPS symptoms.

Methods

A systematic search was conducted across PubMed, ScienceDirect, SCOPUS, and Web of Science databases in accordance with Preferred Peporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Eligible studies included case series and clinical reports from the last 15 years that assessed pain outcomes after VR in men diagnosed with PVPS. Primary outcomes included pain resolution or reduction postoperatively, measured through visual analogue pain scores or patient-reported outcomes.

Results

Five studies involving 123 patients were included, encompassing vasovasostomy, vasoepididymostomy, and robotic-assisted techniques. All studies reported symptomatic improvement after VR, with pain score reductions ranging from 60% to 83%. While 2 studies used validated pain scoring systems before intervention and post intervention, the remaining studies reported other subjective or percentage-based improvements. Across all studies, VR was associated with high rates of patient satisfaction and willingness to undergo the procedure again.

Conclusions

VR seems to offer meaningful pain relief in patients suffering from PVPS. However, further high-quality prospective studies and randomized controlled trials are needed to concretely establish its efficacy, compare it with alternative treatments, and develop standardized treatment algorithms.

Read the guide

Topics

Related research

Reproductive Surgery › Sterilization and Reversal › Sterilization Reversal
Reza Lahiji, Bilal Safdar, Alex Abdollahzadeh, Jacob McKenzie, Craig Hong, Adam Braunschweig, Manuel De Jesus-Escano, Gregory Palmateer, Dattatraya Patil, Viraj A Master, Cara B Cimmino
R Lahiji, B Safdar, Alexander Abdollahzadeh, Alexandra Abdollahzadeh, A Abdollahzadeh, J McKenzie, C Hong, A Braunschweig, M Jesus-Escano, Greg Palmateer, G Palmateer, D Patil, V Master, C Cimmino
PMID 41104924 41104924 DOI 10.1097/UPJ.0000000000000909 10.1097/UPJ.0000000000000909 Lahiji et al. 2026, Lahiji 2026